5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.
about
Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia.5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy.Towards personalized, tumour-specific, therapeutic vaccines for cancer.Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer.A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft models.Next Generation Cancer Vaccines-Make It Personal!
P2860
5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.
@en
type
label
5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.
@en
prefLabel
5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.
@en
P2860
P1476
5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.
@en
P2093
Peter L Stern
Richard Harrop
P2860
P2888
P304
P356
10.1007/S00262-016-1917-3
P577
2016-10-18T00:00:00Z
P6179
1052216677